Alfortville, France

Bernadette Mandard

This inventor holds 3 USPTO granted patents. Top assignee: Rhone-Poulenc Rorer S.a.. Active years: 1995-2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Alfortville, FR (1995)
  • Mareuil Sur Cher, FR (2000)

Company Filing History:


Years Active: 1995-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Bernadette Mandard

Introduction

Bernadette Mandard is a notable inventor based in Alfortville, France. She has made significant contributions to the field of chemistry, particularly in the area of pharmaceutical development. With a total of 3 patents to her name, her work has had a meaningful impact on the industry.

Latest Patents

Mandard's latest patents include innovative processes that enhance the preparation and extraction of valuable compounds. Her notable patents are:

1. Process for the preparation of 4-acetoxy-2.alpha.-benzoyloxy-5.beta.

2. Process for obtaining 10-deacetylbaccatin III.

3. Process for producing 10-deacetylbaccatin III from the various parts of the yew (Taxus sp.) by extraction and selective crystallization from a methanolic extract of the plant mass.

Career Highlights

Throughout her career, Mandard has worked with Rhone-Poulenc Rorer S.A., a company known for its advancements in pharmaceuticals. Her expertise in chemical processes has positioned her as a valuable asset in her field.

Collaborations

Mandard has collaborated with esteemed colleagues such as Jean-Claude Gaullier and Rodolphe Margraff. These partnerships have further enriched her research and development efforts.

Conclusion

Bernadette Mandard's contributions to the field of chemistry and her innovative patents demonstrate her commitment to advancing pharmaceutical science. Her work continues to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…